Logo image
Biophysical and Biochemical Characterization of Structurally Diverse Small Molecule Hits for KRAS Inhibition
Journal article   Peer reviewed

Biophysical and Biochemical Characterization of Structurally Diverse Small Molecule Hits for KRAS Inhibition

Cynthia V Pagba, Amit K Gupta, Kasuni Dilsha, Parisa Sadrpour, Jacob Jakubec, Priyanka Prakash, Dharini van der Hoeven, Kwang-Jin Cho, Scott Gilbertson and Alemayehu A Gorfe
Chembiochem : a European journal of chemical biology, Vol.25(7), pp.e202300827-n/a
04/02/2024
DOI: 10.1002/cbic.202300827
PMID: 38349283
url
https://doi.org/10.1002/cbic.202300827View
Published (Version of record) Open Access

Abstract

We describe six compounds as early hits for the development of direct inhibitors of KRAS, an important anticancer drug target. We show that these compounds bind to KRAS with affinities in the low micromolar range and exert different effects on its interactions with binding partners. Some of the compounds exhibit selective binding to the activated form of KRAS and inhibit signal transduction through both the MAPK or the phosphatidylinositide 3-kinase PI3K-protein kinase B (AKT) pathway in cells expressing mutant KRAS. Most inhibit intrinsic and/or SOS-mediated KRAS activation while others inhibit RAS-effector interaction. We propose these compounds as starting points for the development of non-covalent allosteric KRAS inhibitors.
Antineoplastic Agents - pharmacology Cell Line, Tumor Mutation Proto-Oncogene Proteins p21(ras) - genetics Signal Transduction

Details

Metrics

1 Record Views
Logo image